• Profile
Close

Intraperitoneal transfusion for severe, early-onset Rhesus disease requiring treatment before 20 weeks of gestation: A consecutive case series

European Journal of Obstetrics & Gynecology and Reproductive Biology Oct 27, 2019

Crawford NEH, et al. - Researchers assessed a 10-year consecutive case series of pregnancies affected by severe, early-onset Rhesus isoimmunization treated with fetal intraperitoneal transfusions (IPTs) before 20 weeks gestation at Wessex Fetal Medicine Unit, Southampton, UK, in order to define the management and perinatal outcomes of these pregnancies. Based on obstetric history and maternal antibody levels at the time of booking, identification of women with fetuses at risk of early-onset fetal anemia (before 20 weeks gestation) was done. Middle cerebral artery peak systolic velocity, as an indicator of fetal anemia, assisted in the decision to initiate transfusion. At the first transfusion, no fetus was hydropic. They assessed 11 fetuses who underwent 45 IPTs. After 33 weeks of gestation, 10/11 (91%) were delivered. In previous studies, a perinatal loss rate of 24% was reported in correlation with early intrauterine transfusion in gestations below 20 weeks using the intravascular route. As per this series, intraperitoneal transfusion seems to be a safe and efficacious treatment for severe fetal anemia at early gestations where vascular access is challenging.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay